<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T10:34:27Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/120743" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/120743</identifier><datestamp>2026-05-15T17:53:10Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Brady, Alexander</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair" lang="en_US">McGeachy, Mandy</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Rudd, Brian</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Fowell, Deborah</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Koretzky, Gary</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-04-02T18:48:56Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2026-04-02T18:48:56Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2025-08</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 15160</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 32167940</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/120743</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.7298/wt8b-m117</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">17422457</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">236 pages</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">CD28 ligation provides critical signals that modulate activated T cell fate. In a humanto mouse reverse-engineering approach, a single amino acid substitution adjacent to the C-terminal proline-rich domain created CD28A210P mice with enhanced CD28 Cterminal signaling. CD28A210P mice experienced pro-inflammatory responses to CD28 superagonist antibody, analogous to severe cytokine storm induced in a human clinical trial, with a striking increase of activated CD8 T cells. In acute and chronic viral infections, early activation and expansion of CD28A210P CD8 effector and stem-like T cells increased leading to increased memory T cell generation following acute infection and increased stem-like T cells late in chronic infection, that were further increased by PD-L1 blockade. Analogous to chronic infection, CD28A210P tumor-bearing mice had increased tumor infiltrating stem-like T cells, which delayed, but ultimately could not control tumor growth. Mechanistically, CD28 A210P enhanced JunB, IL-2, and inhibitory receptors driven by MEK1/2. Depletion of CD8 T cells or inhibition of MEK1/2 prevented the pro-inflammatory response to CD28 superagonist antibody in CD28A210P mice without inhibiting Foxp3+ regulatory T cell expansion. Thus, ‘humanized’ PYAP mice reveal key roles for CD28 C-terminal signaling strength in CD8 activation, effector and stem-like differentiation, and maintenance of stem-like T cells during acute and chronic viral infection and cancer.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">CD28</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">CD28 superagonist</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">LCMV</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">stem-like T cell</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">T cell</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Tpex</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">A SINGLE AMINO ACID SUBSITUTION HUMANIZES MOUSE CD28, INCREASING EFFECTOR AND STEM-LIKE T CELL ACTIVATION</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Biomedical and Biological Sciences</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Biomedical and Biological Sciences</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810.2</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://ecommons.cornell.edu/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Brady, Alexander</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="1e4a891c-31ec-4064-a081-0edf51a01b42">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en&lt;/Language>
   	&lt;Title>A SINGLE AMINO ACID SUBSITUTION HUMANIZES MOUSE CD28, INCREASING EFFECTOR AND STEM-LIKE T CELL ACTIVATION&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2025-08&lt;/PublicationDate>
   	&lt;DOI>https://doi.org/10.7298/wt8b-m117&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Brady, Alexander&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;Keyword>CD28&lt;/Keyword>
    &lt;Keyword>CD28 superagonist&lt;/Keyword>
    &lt;Keyword>LCMV&lt;/Keyword>
    &lt;Keyword>stem-like T cell&lt;/Keyword>
    &lt;Keyword>T cell&lt;/Keyword>
    &lt;Keyword>Tpex&lt;/Keyword>
   	&lt;Abstract>CD28 ligation provides critical signals that modulate activated T cell fate. In a humanto mouse reverse-engineering approach, a single amino acid substitution adjacent to the C-terminal proline-rich domain created CD28A210P mice with enhanced CD28 Cterminal signaling. CD28A210P mice experienced pro-inflammatory responses to CD28 superagonist antibody, analogous to severe cytokine storm induced in a human clinical trial, with a striking increase of activated CD8 T cells. In acute and chronic viral infections, early activation and expansion of CD28A210P CD8 effector and stem-like T cells increased leading to increased memory T cell generation following acute infection and increased stem-like T cells late in chronic infection, that were further increased by PD-L1 blockade. Analogous to chronic infection, CD28A210P tumor-bearing mice had increased tumor infiltrating stem-like T cells, which delayed, but ultimately could not control tumor growth. Mechanistically, CD28 A210P enhanced JunB, IL-2, and inhibitory receptors driven by MEK1/2. Depletion of CD8 T cells or inhibition of MEK1/2 prevented the pro-inflammatory response to CD28 superagonist antibody in CD28A210P mice without inhibiting Foxp3+ regulatory T cell expansion. Thus, ‘humanized’ PYAP mice reveal key roles for CD28 C-terminal signaling strength in CD8 activation, effector and stem-like differentiation, and maintenance of stem-like T cells during acute and chronic viral infection and cancer.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>